These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 26085687)

  • 1. Preferential Recruitment of Neutrophils into the Cerebellum and Brainstem Contributes to the Atypical Experimental Autoimmune Encephalomyelitis Phenotype.
    Liu Y; Holdbrooks AT; Meares GP; Buckley JA; Benveniste EN; Qin H
    J Immunol; 2015 Aug; 195(3):841-52. PubMed ID: 26085687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signal transducer and activator of transcription-3/suppressor of cytokine signaling-3 (STAT3/SOCS3) axis in myeloid cells regulates neuroinflammation.
    Qin H; Yeh WI; De Sarno P; Holdbrooks AT; Liu Y; Muldowney MT; Reynolds SL; Yanagisawa LL; Fox TH; Park K; Harrington LE; Raman C; Benveniste EN
    Proc Natl Acad Sci U S A; 2012 Mar; 109(13):5004-9. PubMed ID: 22411837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficiency of Socs3 leads to brain-targeted EAE via enhanced neutrophil activation and ROS production.
    Yan Z; Yang W; Parkitny L; Gibson SA; Lee KS; Collins F; Deshane JS; Cheng W; Weinmann AS; Wei H; Qin H; Benveniste EN
    JCI Insight; 2019 Apr; 5(9):. PubMed ID: 30939124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An IFNγ/CXCL2 regulatory pathway determines lesion localization during EAE.
    Stoolman JS; Duncker PC; Huber AK; Giles DA; Washnock-Schmid JM; Soulika AM; Segal BM
    J Neuroinflammation; 2018 Jul; 15(1):208. PubMed ID: 30012158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-409-3p and MiR-1896 co-operatively participate in IL-17-induced inflammatory cytokine production in astrocytes and pathogenesis of EAE mice via targeting SOCS3/STAT3 signaling.
    Liu X; Zhou F; Yang Y; Wang W; Niu L; Zuo D; Li X; Hua H; Zhang B; Kou Y; Guo J; Kong F; Pan W; Gao D; Meves JM; Sun H; Xue M; Zhang Q; Wang Y; Tang R
    Glia; 2019 Jan; 67(1):101-112. PubMed ID: 30294880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Site-specific chemokine expression regulates central nervous system inflammation and determines clinical phenotype in autoimmune encephalomyelitis.
    Stoolman JS; Duncker PC; Huber AK; Segal BM
    J Immunol; 2014 Jul; 193(2):564-70. PubMed ID: 24928987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exacerbation of experimental autoimmune encephalomyelitis in ceramide synthase 6 knockout mice is associated with enhanced activation/migration of neutrophils.
    Eberle M; Ebel P; Mayer CA; Barthelmes J; Tafferner N; Ferreiros N; Ulshöfer T; Henke M; Foerch C; de Bazo AM; Grösch S; Geisslinger G; Willecke K; Schiffmann S
    Immunol Cell Biol; 2015 Oct; 93(9):825-36. PubMed ID: 25833068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemokine expression by central nervous system resident cells and infiltrating neutrophils during experimental autoimmune encephalomyelitis in the BALB/c mouse.
    Nygårdas PT; Määttä JA; Hinkkanen AE
    Eur J Immunol; 2000 Jul; 30(7):1911-8. PubMed ID: 10940880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SOCS3 deficiency promotes M1 macrophage polarization and inflammation.
    Qin H; Holdbrooks AT; Liu Y; Reynolds SL; Yanagisawa LL; Benveniste EN
    J Immunol; 2012 Oct; 189(7):3439-48. PubMed ID: 22925925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of ceramide synthase 2 suppresses the development of experimental autoimmune encephalomyelitis by impairing the migratory capacity of neutrophils.
    Barthelmes J; de Bazo AM; Pewzner-Jung Y; Schmitz K; Mayer CA; Foerch C; Eberle M; Tafferner N; Ferreirós N; Henke M; Geisslinger G; Futerman AH; Grösch S; Schiffmann S
    Brain Behav Immun; 2015 May; 46():280-92. PubMed ID: 25697397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IFN-gamma determines distinct clinical outcomes in autoimmune encephalomyelitis.
    Wensky AK; Furtado GC; Marcondes MC; Chen S; Manfra D; Lira SA; Zagzag D; Lafaille JJ
    J Immunol; 2005 Feb; 174(3):1416-23. PubMed ID: 15661899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloid depletion of SOCS3 enhances LPS-induced acute lung injury through CCAAT/enhancer binding protein δ pathway.
    Yan C; Ward PA; Wang X; Gao H
    FASEB J; 2013 Aug; 27(8):2967-76. PubMed ID: 23585399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-17 promotes autoimmunity by triggering a positive-feedback loop via interleukin-6 induction.
    Ogura H; Murakami M; Okuyama Y; Tsuruoka M; Kitabayashi C; Kanamoto M; Nishihara M; Iwakura Y; Hirano T
    Immunity; 2008 Oct; 29(4):628-36. PubMed ID: 18848474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRPM2 Exacerbates Central Nervous System Inflammation in Experimental Autoimmune Encephalomyelitis by Increasing Production of CXCL2 Chemokines.
    Tsutsui M; Hirase R; Miyamura S; Nagayasu K; Nakagawa T; Mori Y; Shirakawa H; Kaneko S
    J Neurosci; 2018 Sep; 38(39):8484-8495. PubMed ID: 30201769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition.
    Kroenke MA; Carlson TJ; Andjelkovic AV; Segal BM
    J Exp Med; 2008 Jul; 205(7):1535-41. PubMed ID: 18573909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SOCS3 is a physiological negative regulator for granulopoiesis and granulocyte colony-stimulating factor receptor signaling.
    Kimura A; Kinjyo I; Matsumura Y; Mori H; Mashima R; Harada M; Chien KR; Yasukawa H; Yoshimura A
    J Biol Chem; 2004 Feb; 279(8):6905-10. PubMed ID: 14699146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of SOCS3 in lung CD4+ T cells in a mouse model of chronic PA lung infection and suppression of Th17‑mediated neutrophil recruitment in exogenous SOCS3 transfer in vitro.
    Ding FM; Liao RM; Chen YQ; Xie GG; Zhang PY; Shao P; Zhang M
    Mol Med Rep; 2017 Jul; 16(1):778-786. PubMed ID: 28560450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressor of cytokine signalling-3 at pathological levels does not regulate lipopolysaccharide or interleukin-10 control of tumour necrosis factor-alpha production by human monocytes.
    Prêle CM; Keith-Magee AL; Yerkovich ST; Murcha M; Hart PH
    Immunology; 2006 Sep; 119(1):8-17. PubMed ID: 16925527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCR3 signaling in glial cells ameliorates experimental autoimmune encephalomyelitis by restraining the generation of a pro-Th17 cytokine milieu and reducing CNS-infiltrating Th17 cells.
    Chung CY; Liao F
    J Neuroinflammation; 2016 Apr; 13(1):76. PubMed ID: 27068264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Site-specific production of IL-6 in the central nervous system retargets and enhances the inflammatory response in experimental autoimmune encephalomyelitis.
    Quintana A; Müller M; Frausto RF; Ramos R; Getts DR; Sanz E; Hofer MJ; Krauthausen M; King NJ; Hidalgo J; Campbell IL
    J Immunol; 2009 Aug; 183(3):2079-88. PubMed ID: 19597000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.